Literature DB >> 15642371

Inhibition of GSK3beta by indirubins restores HIF-1alpha accumulation under prolonged periods of hypoxia/anoxia.

Steffen E Schnitzer1, Tobias Schmid, Jie Zhou, Gerhard Eisenbrand, Bernhard Brüne.   

Abstract

Hypoxia inducible factor 1 is regulated by the appearance of the HIF-1alpha subunit. HIF-1alpha is subjected to proteasomal destruction or enhanced protein translation, which requires the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. We investigated how PI3K/Akt and glycogen synthase kinase 3beta (GSK3beta) affect HIF-1alpha in human RKO cells under prolonged periods of severe hypoxia/anoxia. 16- to 32-h lasting incubations attenuated Akt activity and decreased HIF-1alpha protein. This was reproduced by blocking PI3K with LY294002. GSK3beta inhibition by indirubins circumvented the effect of hypoxia/anoxia or LY294002 on HIF-1alpha. Ruling stability regulation of HIF-1alpha protein and/or enhanced transcription of HIF-1alpha mRNA via GSK3beta inhibition out is suggestive for translational modulation of HIF-1alpha under the influence of GSK3beta.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642371     DOI: 10.1016/j.febslet.2004.12.023

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.

Authors:  Kuppusamy Balamurugan; Ju-Ming Wang; Hsin-Hwa Tsai; Shikha Sharan; Miriam Anver; Robert Leighty; Esta Sterneck
Journal:  EMBO J       Date:  2010-11-12       Impact factor: 11.598

Review 2.  Hypoxia-Induced Signaling Promotes Prostate Cancer Progression: Exosomes Role as Messenger of Hypoxic Response in Tumor Microenvironment.

Authors:  Gagan Deep; Gati K Panigrahi
Journal:  Crit Rev Oncog       Date:  2015

3.  Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells.

Authors:  Ravinder Tammali; Ashish Saxena; Satish K Srivastava; Kota V Ramana
Journal:  J Biol Chem       Date:  2011-05-16       Impact factor: 5.157

4.  Plk3 functions as an essential component of the hypoxia regulatory pathway by direct phosphorylation of HIF-1alpha.

Authors:  Dazhong Xu; Yixin Yao; Luo Lu; Max Costa; Wei Dai
Journal:  J Biol Chem       Date:  2010-10-01       Impact factor: 5.157

5.  Regulation of PTEN stability and activity by Plk3.

Authors:  Dazhong Xu; Yixin Yao; Xuejun Jiang; Luo Lu; Wei Dai
Journal:  J Biol Chem       Date:  2010-10-12       Impact factor: 5.157

Review 6.  Natural product-derived small molecule activators of hypoxia-inducible factor-1 (HIF-1).

Authors:  Dale G Nagle; Yu-Dong Zhou
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

7.  Gene expression profiling in equine polysaccharide storage myopathy revealed inflammation, glycogenesis inhibition, hypoxia and mitochondrial dysfunctions.

Authors:  Eric Barrey; Elodie Mucher; Nicolas Jeansoule; Thibaut Larcher; Lydie Guigand; Bérénice Herszberg; Stéphane Chaffaux; Gérard Guérin; Xavier Mata; Philippe Benech; Marielle Canale; Olivier Alibert; Péguy Maltere; Xavier Gidrol
Journal:  BMC Vet Res       Date:  2009-08-07       Impact factor: 2.741

8.  Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells.

Authors:  Rachida S Belaiba; Steve Bonello; Christian Zähringer; Stefanie Schmidt; John Hess; Thomas Kietzmann; Agnes Görlach
Journal:  Mol Biol Cell       Date:  2007-09-26       Impact factor: 4.138

9.  GSK-3 and Wnt Signaling in Neurogenesis and Bipolar Disorder.

Authors:  Alexander J Valvezan; Peter S Klein
Journal:  Front Mol Neurosci       Date:  2012-01-30       Impact factor: 5.639

10.  Temporal regulation of HIF-1 and NF-κB in hypoxic hepatocarcinoma cells.

Authors:  Yuan Jiang; Ying Zhu; Xinxin Wang; Juan Gong; Chunyan Hu; Bo Guo; Bo Zhu; Yongsheng Li
Journal:  Oncotarget       Date:  2015-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.